Skip to main content
Jinyu Bio-Technology Co.,Ltd. logo

Jinyu Bio-Technology Co.,Ltd. — Investor Relations & Filings

Ticker · 600201 ISIN · CNE000000Y37 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,777 across all filing types
Latest filing 2017-07-10 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 600201

About Jinyu Bio-Technology Co.,Ltd.

http://jinyubiotech.com/

Jinyu Bio-Technology Co., Ltd. focuses on the research, development, and manufacturing of veterinary biological products and pharmaceuticals. The company is a prominent supplier of animal vaccines, particularly specializing in Foot-and-Mouth Disease (FMD) vaccines, brucellosis vaccines, and solutions for swine and poultry diseases. It utilizes advanced biotechnology platforms, including large-scale suspension culture and high-efficiency purification processes, to produce high-titer, high-purity biologicals. The organization operates sophisticated research facilities and Biosafety Level 3 (P3) laboratories to support the development of diagnostic reagents and preventive treatments. Its operations center on enhancing animal health through scientific innovation, providing comprehensive disease control strategies for the global livestock industry and large-scale agricultural operations.

Recent filings

Filing Released Lang Actions
关于参与竞拍辽宁益康生物股份有限公司1400万股股权转让和4000万股增资扩股项目的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the company's participation and successful bid in a share transfer and capital increase project involving another company. It details the board's approval, the bidding process, and the subsequent steps to be taken. There are no financial statements, quarterly or annual results, or detailed financial analysis included. The document is a progress update on a capital transaction rather than a full financing report or capital structure change announcement. Given the content focuses on a financing-related transaction update but does not detail new financing terms or capital structure changes explicitly, it best fits the category of Capital/Financing Update (CAP). The document length is short and it is not a report publication announcement or regulatory filing. Therefore, the classification is CAP with high confidence.
2017-07-10 Chinese
关于第一大股东股份质押的公告
Major Shareholding Notification Classification · 95% confidence The document is a public announcement regarding the pledge of shares by the company's largest shareholder. It details the number of shares pledged, the pledge period, and the shareholder's financial status related to the pledge. There is no financial report, earnings data, or management discussion. The content fits the category of a Major Shareholding Notification, as it involves disclosure of significant share ownership and pledge changes by a major shareholder.
2017-07-03 Chinese
关于拟参与竞拍辽宁益康生物股份有限公司1400万股股权转让和4000万股增资扩股项目的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by 金宇生物技术股份有限公司 regarding its intention to participate in a bidding process for acquiring shares and capital increase in 辽宁益康生物股份有限公司. It details the transaction overview, parties involved, shareholding structure, financial data of the target company, transaction conditions, and risk warnings. The document is a formal public announcement about a capital investment and share acquisition transaction, not a financial report, earnings release, or regulatory filing. It does not contain financial statements or detailed financial analysis but focuses on the capital transaction and investment update. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is under 5,000 characters, but it is not merely announcing the publication of a report; it is announcing a financing transaction. Hence, the classification is CAP with high confidence.
2017-06-26 Chinese
第九届董事会第九次会议决议公告
Board/Management Information Classification · 95% confidence The document is a board meeting resolution announcement from the company 金宇生物技术股份有限公司 regarding the decision to participate in a bidding process for equity transfer and capital increase of another company. It includes details of the board meeting, voting results, and authorization to management. There are no financial statements or detailed financial performance data. The document is an announcement of board/management decisions and changes, not a full report or financial release. Therefore, it fits the category of Board/Management Information (MANG). The document length is short and focused on board resolutions, confirming this classification.
2017-06-26 Chinese
监事会关于公司2017年度限制性股票股权激励计划首次授予事项的核查意见
Capital/Financing Update Classification · 95% confidence The document is a supervisory board's verification opinion on the company's 2017 restricted stock equity incentive plan's first grant. It discusses compliance with laws, approval of grant price adjustments, and confirmation of eligible recipients. It is not a financial report, earnings release, or regulatory filing but a formal opinion related to equity incentive plans. This fits best under Capital/Financing Update (CAP) as it relates to stock-based compensation and equity grants.
2017-06-13 Chinese
第九届监事会第七次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at a supervisory board meeting of a company, specifically regarding adjustments to a stock incentive plan and the granting of restricted stock. It includes voting results and confirms compliance with relevant laws and company articles. There is no financial report, earnings data, or detailed financial statements. The document is an official announcement of board/management decisions related to stock incentives, which fits the category of Board/Management Information (MANG). The document length is short and it is not a report publication or certification. Therefore, the classification is MANG with high confidence.
2017-06-13 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.